Background illustration for clinical trials search

Paid Clinical Trials Cincinnati

Discover 1,168 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Cincinnati OH, Louisville KY, Chattanooga TN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase 3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Cincinnati OH, Fairfield OH, Louisville KY, Avon OH,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase 3, Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Cincinnati OH, Indianapolis IN, Columbus OH,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase 2, Recruiting

MYLUNG Consortium Part 3: Observational Study

for
Carcinoma, Non-Small-Cell Lung
Location: Cincinnati OH, Chicago Ridge IL, Blacksburg VA,
Sponsor: US Oncology Research

Sex: All

Age: 18+

Code: NCT05885698

Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: Cincinnati OH, Fort Wayne IN, Akron OH, Nashville TN,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Cincinnati OH, Lexington KY, Columbus OH, Cleveland OH,
Sponsor: Deciphera Pharmaceuticals, LLC

Sex: All

Age: 18+

Code: NCT06619561

Phase 2, Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for
Diffuse Large B-Cell Lymphoma
Location: Cincinnati OH, Lexington KY, Louisville KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06717347

Phase 3, Recruiting

Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

for
Small Cell Lung Cancer Extensive Stage
Location: Cincinnati OH, Fairfield OH, Canton OH, St Louis MO,
Sponsor: Genprex, Inc.

Sex: All

Age: 18+

Code: NCT05703971

Phase 1, Phase 2, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Cincinnati OH, Cleveland OH, Ann Arbor MI,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase 3, Recruiting

Pan Tumor Rollover Study

for
Cancer
Location: Cincinnati OH, Louisville KY, Columbus OH, Nashville TN,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT03899155

Phase 2, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Cincinnati OH, Centerville OH, Lexington KY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

for
Neoplasms
Location: Cincinnati OH, Lexington KY, Louisville KY,
Sponsor: Celgene

Sex: All

Age: 0+

Code: NCT03435796

Phase 2, Phase 3, Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

for
Extensive-Stage Small Cell Lung Cancer
Location: Cincinnati OH, Nashville TN, Roanoke VA, Peoria IL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06646276

Phase 3, Recruiting

APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML

for
Acute Myeloid Leukemia (AML)
Location: Cincinnati, OH, Canton OH, Fairway KS, Dallas TX,
Sponsor: Aptevo Therapeutics

Sex: All

Age: 18+

Code: NCT06634394

Phase 1, Recruiting

A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

for
Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2
Location: Cincinnati OH, Southfield MI, Lansing MI, Denver NC,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT07646678

Phase 2, Phase 3, Recruiting

An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumors
Location: Cincinnati OH, Detroit MI, Nashville TN, Chicago IL,
Sponsor: Teva Branded Pharmaceutical Products R&D LLC

Sex: All

Age: 18+

Code: NCT06480552

Phase 1, Recruiting

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

for
Breast Cancer
Location: Edgewood KY, Louisville KY, Newburgh IN, Canton OH,
Sponsor: Exact Sciences Corporation

Sex: All

Age: 18+

Code: NCT06401421

Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Edgewood KY, Columbus OH, Knoxville TN, Detroit MI,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase 3, Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Location: Edgewood KY, Cleveland OH, Nashville TN, Pittsburgh PA,
Sponsor: LigaChem Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06774963

Phase 1, Recruiting

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Edgewood KY, Indianapolis IN, Columbus OH, Ann Arbor MI,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07409272

Phase 3, Recruiting